カテゴリ： 世界, 医療/バイオ, Market Monitor Global

皮膚科処方薬のグローバル市場展望 2023年-2029年：経口、局所

■ 英語タイトル：Prescription Dermatological Medications Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8594）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8594
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：71
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[皮膚科処方薬のグローバル市場展望 2023年-2029年：経口、局所]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の皮膚科処方薬市場規模と予測を収録しています。・世界の皮膚科処方薬市場：売上、2018年-2023年、2024年-2029年
・世界の皮膚科処方薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の皮膚科処方薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

皮膚科処方薬のグローバル主要企業は、Mylan Pharmaceuticals、 Pfizer、 Almirall、 Bausch Health、 Barrier Therapeutics、 PharmaDerm、 Bristol-Myers Squibb、 Galderma、 Novartisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、皮膚科処方薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の皮膚科処方薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の皮膚科処方薬市場：タイプ別市場シェア、2022年
・経口、局所

世界の皮膚科処方薬市場：用途別、2018年-2023年、2024年-2029年
世界の皮膚科処方薬市場：用途別市場シェア、2022年
・病院薬局、オンライン薬局、小売薬局

世界の皮膚科処方薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の皮膚科処方薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における皮膚科処方薬のグローバル売上、2018年-2023年
・主要企業における皮膚科処方薬のグローバル売上シェア、2022年
・主要企業における皮膚科処方薬のグローバル販売量、2018年-2023年
・主要企業における皮膚科処方薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Mylan Pharmaceuticals、 Pfizer、 Almirall、 Bausch Health、 Barrier Therapeutics、 PharmaDerm、 Bristol-Myers Squibb、 Galderma、 Novartis

*************************************************************

・調査・分析レポートの概要
皮膚科処方薬市場の定義
市場セグメント
世界の皮膚科処方薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の皮膚科処方薬市場規模
世界の皮膚科処方薬市場規模：2022年 VS 2029年
世界の皮膚科処方薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの皮膚科処方薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の皮膚科処方薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口、局所
皮膚科処方薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、オンライン薬局、小売薬局
皮膚科処方薬の用途別グローバル売上・予測

・地域別市場分析
地域別皮膚科処方薬市場規模 2022年と2029年
地域別皮膚科処方薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Mylan Pharmaceuticals、 Pfizer、 Almirall、 Bausch Health、 Barrier Therapeutics、 PharmaDerm、 Bristol-Myers Squibb、 Galderma、 Novartis
...

Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications.
This report aims to provide a comprehensive presentation of the global market for Prescription Dermatological Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Dermatological Medications. This report contains market size and forecasts of Prescription Dermatological Medications in global, including the following market information:
Global Prescription Dermatological Medications Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prescription Dermatological Medications Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Prescription Dermatological Medications companies in 2022 (%)
The global Prescription Dermatological Medications market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prescription Dermatological Medications include Mylan Pharmaceuticals, Pfizer, Almirall, Bausch Health, Barrier Therapeutics, PharmaDerm, Bristol-Myers Squibb, Galderma and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Dermatological Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Dermatological Medications Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Dermatological Medications Market Segment Percentages, by Type, 2022 (%)
Oral
Topical
Global Prescription Dermatological Medications Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Dermatological Medications Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Prescription Dermatological Medications Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Dermatological Medications Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Dermatological Medications revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prescription Dermatological Medications revenues share in global market, 2022 (%)
Key companies Prescription Dermatological Medications sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prescription Dermatological Medications sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan Pharmaceuticals
Pfizer
Almirall
Bausch Health
Barrier Therapeutics
PharmaDerm
Bristol-Myers Squibb
Galderma
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prescription Dermatological Medications, market overview.
Chapter 2: Global Prescription Dermatological Medications market size in revenue and volume.
Chapter 3: Detailed analysis of Prescription Dermatological Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription Dermatological Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prescription Dermatological Medications capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Prescription Dermatological Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prescription Dermatological Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prescription Dermatological Medications Overall Market Size
2.1 Global Prescription Dermatological Medications Market Size: 2022 VS 2029
2.2 Global Prescription Dermatological Medications Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Prescription Dermatological Medications Sales: 2018-2029
3 Company Landscape
3.1 Top Prescription Dermatological Medications Players in Global Market
3.2 Top Global Prescription Dermatological Medications Companies Ranked by Revenue
3.3 Global Prescription Dermatological Medications Revenue by Companies
3.4 Global Prescription Dermatological Medications Sales by Companies
3.5 Global Prescription Dermatological Medications Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prescription Dermatological Medications Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prescription Dermatological Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prescription Dermatological Medications Players in Global Market
3.8.1 List of Global Tier 1 Prescription Dermatological Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Prescription Dermatological Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Prescription Dermatological Medications Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Topical
4.2 By Type – Global Prescription Dermatological Medications Revenue & Forecasts
4.2.1 By Type – Global Prescription Dermatological Medications Revenue, 2018-2023
4.2.2 By Type – Global Prescription Dermatological Medications Revenue, 2024-2029
4.2.3 By Type – Global Prescription Dermatological Medications Revenue Market Share, 2018-2029
4.3 By Type – Global Prescription Dermatological Medications Sales & Forecasts
4.3.1 By Type – Global Prescription Dermatological Medications Sales, 2018-2023
4.3.2 By Type – Global Prescription Dermatological Medications Sales, 2024-2029
4.3.3 By Type – Global Prescription Dermatological Medications Sales Market Share, 2018-2029
4.4 By Type – Global Prescription Dermatological Medications Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Prescription Dermatological Medications Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application – Global Prescription Dermatological Medications Revenue & Forecasts
5.2.1 By Application – Global Prescription Dermatological Medications Revenue, 2018-2023
5.2.2 By Application – Global Prescription Dermatological Medications Revenue, 2024-2029
5.2.3 By Application – Global Prescription Dermatological Medications Revenue Market Share, 2018-2029
5.3 By Application – Global Prescription Dermatological Medications Sales & Forecasts
5.3.1 By Application – Global Prescription Dermatological Medications Sales, 2018-2023
5.3.2 By Application – Global Prescription Dermatological Medications Sales, 2024-2029
5.3.3 By Application – Global Prescription Dermatological Medications Sales Market Share, 2018-2029
5.4 By Application – Global Prescription Dermatological Medications Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Prescription Dermatological Medications Market Size, 2022 & 2029
6.2 By Region – Global Prescription Dermatological Medications Revenue & Forecasts
6.2.1 By Region – Global Prescription Dermatological Medications Revenue, 2018-2023
6.2.2 By Region – Global Prescription Dermatological Medications Revenue, 2024-2029
6.2.3 By Region – Global Prescription Dermatological Medications Revenue Market Share, 2018-2029
6.3 By Region – Global Prescription Dermatological Medications Sales & Forecasts
6.3.1 By Region – Global Prescription Dermatological Medications Sales, 2018-2023
6.3.2 By Region – Global Prescription Dermatological Medications Sales, 2024-2029
6.3.3 By Region – Global Prescription Dermatological Medications Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Prescription Dermatological Medications Revenue, 2018-2029
6.4.2 By Country – North America Prescription Dermatological Medications Sales, 2018-2029
6.4.3 US Prescription Dermatological Medications Market Size, 2018-2029
6.4.4 Canada Prescription Dermatological Medications Market Size, 2018-2029
6.4.5 Mexico Prescription Dermatological Medications Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Prescription Dermatological Medications Revenue, 2018-2029
6.5.2 By Country – Europe Prescription Dermatological Medications Sales, 2018-2029
6.5.3 Germany Prescription Dermatological Medications Market Size, 2018-2029
6.5.4 France Prescription Dermatological Medications Market Size, 2018-2029
6.5.5 U.K. Prescription Dermatological Medications Market Size, 2018-2029
6.5.6 Italy Prescription Dermatological Medications Market Size, 2018-2029
6.5.7 Russia Prescription Dermatological Medications Market Size, 2018-2029
6.5.8 Nordic Countries Prescription Dermatological Medications Market Size, 2018-2029
6.5.9 Benelux Prescription Dermatological Medications Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Prescription Dermatological Medications Revenue, 2018-2029
6.6.2 By Region – Asia Prescription Dermatological Medications Sales, 2018-2029
6.6.3 China Prescription Dermatological Medications Market Size, 2018-2029
6.6.4 Japan Prescription Dermatological Medications Market Size, 2018-2029
6.6.5 South Korea Prescription Dermatological Medications Market Size, 2018-2029
6.6.6 Southeast Asia Prescription Dermatological Medications Market Size, 2018-2029
6.6.7 India Prescription Dermatological Medications Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Prescription Dermatological Medications Revenue, 2018-2029
6.7.2 By Country – South America Prescription Dermatological Medications Sales, 2018-2029
6.7.3 Brazil Prescription Dermatological Medications Market Size, 2018-2029
6.7.4 Argentina Prescription Dermatological Medications Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Prescription Dermatological Medications Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Prescription Dermatological Medications Sales, 2018-2029
6.8.3 Turkey Prescription Dermatological Medications Market Size, 2018-2029
6.8.4 Israel Prescription Dermatological Medications Market Size, 2018-2029
6.8.5 Saudi Arabia Prescription Dermatological Medications Market Size, 2018-2029
6.8.6 UAE Prescription Dermatological Medications Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Mylan Pharmaceuticals
7.1.1 Mylan Pharmaceuticals Company Summary
7.1.2 Mylan Pharmaceuticals Business Overview
7.1.3 Mylan Pharmaceuticals Prescription Dermatological Medications Major Product Offerings
7.1.4 Mylan Pharmaceuticals Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.1.5 Mylan Pharmaceuticals Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Prescription Dermatological Medications Major Product Offerings
7.2.4 Pfizer Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Almirall
7.3.1 Almirall Company Summary
7.3.2 Almirall Business Overview
7.3.3 Almirall Prescription Dermatological Medications Major Product Offerings
7.3.4 Almirall Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.3.5 Almirall Key News & Latest Developments
7.4 Bausch Health
7.4.1 Bausch Health Company Summary
7.4.2 Bausch Health Business Overview
7.4.3 Bausch Health Prescription Dermatological Medications Major Product Offerings
7.4.4 Bausch Health Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.4.5 Bausch Health Key News & Latest Developments
7.5 Barrier Therapeutics
7.5.1 Barrier Therapeutics Company Summary
7.5.2 Barrier Therapeutics Business Overview
7.5.3 Barrier Therapeutics Prescription Dermatological Medications Major Product Offerings
7.5.4 Barrier Therapeutics Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.5.5 Barrier Therapeutics Key News & Latest Developments
7.6 PharmaDerm
7.6.1 PharmaDerm Company Summary
7.6.2 PharmaDerm Business Overview
7.6.3 PharmaDerm Prescription Dermatological Medications Major Product Offerings
7.6.4 PharmaDerm Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.6.5 PharmaDerm Key News & Latest Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Company Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Prescription Dermatological Medications Major Product Offerings
7.7.4 Bristol-Myers Squibb Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.7.5 Bristol-Myers Squibb Key News & Latest Developments
7.8 Galderma
7.8.1 Galderma Company Summary
7.8.2 Galderma Business Overview
7.8.3 Galderma Prescription Dermatological Medications Major Product Offerings
7.8.4 Galderma Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.8.5 Galderma Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Prescription Dermatological Medications Major Product Offerings
7.9.4 Novartis Prescription Dermatological Medications Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Key News & Latest Developments
8 Global Prescription Dermatological Medications Production Capacity, Analysis
8.1 Global Prescription Dermatological Medications Production Capacity, 2018-2029
8.2 Prescription Dermatological Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Prescription Dermatological Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prescription Dermatological Medications Supply Chain Analysis
10.1 Prescription Dermatological Medications Industry Value Chain
10.2 Prescription Dermatological Medications Upstream Market
10.3 Prescription Dermatological Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prescription Dermatological Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 処方鎮痛薬のグローバル市場展望 2023年-2029年：処方薬 NSAIDs、オピオイド、抗てんかん薬、抗うつ薬、その他
  • 皮膚科用OTC医薬品のグローバル市場展望 2023年-2029年：ニキビ治療薬、皮膚炎治療薬、真菌感染症治療薬
  • 皮膚科用クライオテクノロジーのグローバル市場展望 2023年-2029年：液体窒素療法、ドライアイス療法
  • マイボーム腺機能不全治療薬のグローバル市場展望 2023年-2029年：経口、外用
  • 整形外科用処方薬のグローバル市場展望 2023年-2029年：経口、局所
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8594 )"皮膚科処方薬のグローバル市場展望 2023年-2029年：経口、局所" (英文：Prescription Dermatological Medications Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。